Share on StockTwits

Skyline Medical (NASDAQ:SKLN) CFO Robert L. Myers purchased 5,000 shares of the stock on the open market in a transaction that occurred on Friday, August 22nd. The stock was purchased at an average price of $0.15 per share, with a total value of $750.00. Following the acquisition, the chief financial officer now directly owns 5,000 shares of the company’s stock, valued at approximately $750. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link.

Shares of Skyline Medical (NASDAQ:SKLN) remained flat at $0.1395 during during mid-day trading trading on Tuesday. Skyline Medical has a 52 week low of $0.106 and a 52 week high of $0.47. The stock’s 50-day moving average is $0.13 and its 200-day moving average is $0.16. The company’s market cap is $31.1 million.

Skyline Medical Inc, formerly BioDrain Medical, Inc, is an early stage medical device company. The Company owns patent rights to its products and will distribute its products to medical facilities where bodily and irrigation fluids produced during surgical procedures must be contained, measured, documented, and disposed.

Receive News & Ratings for Skyline Medical Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Skyline Medical Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.